Series C funding round for Endeavor BioMedicines raising $130M in April 2024
Series C funding round for Endeavor BioMedicines raising $130M in April 2024
| Investor | Firm Type | Partner |
|---|
| Private | — | |
AyurMayaLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$292M
Top Valuation
-
Endeavor BioMedicines raised $130M in a Series C round.
The round was announced on 04/01/24.
The round was led by AyurMaya, Karan Takhar.